Thermo Fisher (TMO) EVP Shafer awarded options and adjusted performance stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Shafer Michael D reported acquisition or exercise transactions in this Form 4 filing.
Thermo Fisher Scientific Executive Vice President Michael D. Shafer reported equity awards and adjustments to his holdings. He received a grant of 13,698 stock options and two performance-based stock unit-related common stock awards totaling 4,698 shares.
The filing explains that a performance-based restricted stock unit award granted on February 19, 2025 met its performance criteria on February 25, 2026, with one-third of the shares vesting on February 28, 2026 and 2027, and the final third vesting on February 28, 2028 subject to potential positive or negative adjustment. It also records a 15% reduction to the final tranche of an earlier 2023 performance-based award, resulting in 56 fewer shares than previously reported. The new stock option vests in four equal annual installments beginning on February 28, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Shafer Michael D
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 13,698 | $0.00 | -- |
| Grant/Award | Common Stock | 1,569 | $0.00 | -- |
| Grant/Award | Common Stock | 3,129 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 13,698 shares (Direct);
Common Stock — 20,243.803 shares (Direct)
Footnotes (1)
- Shares represent a performance-based restricted stock unit award granted on February 19, 2025. The Company's Compensation Committee determined on February 25, 2026, that the performance criteria related to this award were satisfied. One-third of the shares vest on February 28, 2026 and 2027. The remaining one-third will vest on February 28, 2028, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2025, through to December 31, 2027. Shares represent an adjustment to the final tranche of a performance-based restricted stock unit award granted on February 22, 2023. On February 25, 2026, the Compensation Committee certified a 15% reduction based on the Company's relative TSR performance over the three-year measurement period, resulting in 56 fewer shares than previously reported. The option vests in four equal annual installments beginning on February 28, 2027.
FAQ
What insider transactions did Thermo Fisher (TMO) report for Michael D. Shafer?
Thermo Fisher reported that Executive Vice President Michael D. Shafer acquired a new stock option grant and additional common shares tied to performance-based stock unit awards. The filing also reflects an adjustment reducing the final tranche of a prior performance award by 56 shares after a 15% performance-related cut.
How many Thermo Fisher (TMO) stock options were granted to Michael D. Shafer?
Michael D. Shafer received a grant of 13,698 stock options. According to the disclosure, these options vest in four equal annual installments starting on February 28, 2027, aligning the executive’s potential future gains with longer-term company performance and continued service at Thermo Fisher.
What performance-based stock unit award changes were disclosed for Thermo Fisher (TMO)?
The company reported that performance criteria for a February 19, 2025 performance-based restricted stock unit award were satisfied on February 25, 2026. One-third vests in 2026 and 2027, with the remaining third vesting in 2028 and subject to adjustment based on relative total shareholder return performance.
Why was there a 15% reduction in a Thermo Fisher (TMO) performance award?
Thermo Fisher’s Compensation Committee certified a 15% reduction to the final tranche of a performance-based restricted stock unit award granted February 22, 2023. This reflected the company’s relative total shareholder return over a three-year period, resulting in 56 fewer shares than previously reported for Michael D. Shafer.
How is long-term performance measured for Thermo Fisher (TMO) executive awards?
For the 2025 performance-based restricted stock unit award, long-term performance is measured by comparing Thermo Fisher’s total shareholder return compound annual growth rate to a defined peer group. The measurement period runs from January 1, 2025 through December 31, 2027, influencing the final vesting adjustment in 2028.